Coronavirus and how we play the adaptation game

We are busy adapting one of our biggest projects to collect data and eventually provide feedback on the best treatment for the novel coronavirus outbreak COVID-19.

Coronavirus mutated( or adapted) recently to give us SARS-CoV-2 and the COVID-19 disease. Adaptation is a great skill for a virus – it's a pretty keen skill for people too, and we are using it to fight back against this disease ... read how »

The largest ever cardiac arrest trial performed in an ICU setting uses Spinnaker in novel ways!

January 2020 saw the last patient enrolled in the TTM2 Trial. Congratulations TTM2 – the largest ever cardiac arrest trial performed in an ICU setting!
The trial has been using our Spinnaker Platform in a novel way, which is what this post is about!

Back in 2017 we were approached by Principle Investigator, Niklas Nielsen, looking for a way to streamline the collection of data for TTM2 and a similar study, TAME.  The 2 studies had very similar data points to collect and there seemed to be an opportunity to save time by collecting data just once and sharing it across both studies. Very quickly it got more complicated than that. Patients could be randomised to TTM2, or TAME, or to participate in both studies. The big question was – could the Spinnaker Platform be adapted to this novel design?

We are very proud of our adaptability so we had a close look at what we could do ... follow the story on our blog »

DollyPartonChallenge

A bit of fun until next week

Congrats TTM2 - 1900/1900